临床药物治疗杂志
臨床藥物治療雜誌
림상약물치료잡지
CLINICAL MEDICATION JOURNAL
2013年
6期
1-4,16
,共5页
抗血小板%围手术期%心脑血管事件%出血%风险
抗血小闆%圍手術期%心腦血管事件%齣血%風險
항혈소판%위수술기%심뇌혈관사건%출혈%풍험
Antiplatelet therapy%Perioperative period%Cardiovascular and cerebrovascular event%Bleeding%Risk
目前由于心脑血管疾病的增多，越来越多的患者应用抗血小板药物作为一级、二级预防，尤其是接受心脏手术后的病人更需要长期接受抗血小板药物治疗。但是，当这些病人需要手术治疗时，术前充分地评估患者心脑血管血栓事件的风险和术后抗血小板药物引起的出血风险至关重要。
目前由于心腦血管疾病的增多，越來越多的患者應用抗血小闆藥物作為一級、二級預防，尤其是接受心髒手術後的病人更需要長期接受抗血小闆藥物治療。但是，噹這些病人需要手術治療時，術前充分地評估患者心腦血管血栓事件的風險和術後抗血小闆藥物引起的齣血風險至關重要。
목전유우심뇌혈관질병적증다，월래월다적환자응용항혈소판약물작위일급、이급예방，우기시접수심장수술후적병인경수요장기접수항혈소판약물치료。단시，당저사병인수요수술치료시，술전충분지평고환자심뇌혈관혈전사건적풍험화술후항혈소판약물인기적출혈풍험지관중요。
At present, with the increasing in cardiovascular and cerebrovascular diseases, more and more patients use antiplatelet drugs for primary or secondary prevention, especial y for the patients undergoing the cardiac surgery who need long-term antiplatelet drug therapy. But when such patients require surgery, it is important to evaluate the preoperative cardiovascular and cerebrovascular events risk and antiplatelet drug-induced bleeding risk in postoperative period. According to the risk classification, we decide how to use the antiplatelet drug therapy during the perioperative period and essential y protect the security of the antiplatelet drug therapy.
